Detlev Riesner

from Wikipedia, the free encyclopedia

Detlev Heinz Riesner (born June 9, 1941 in Stettin ) is a German biophysicist who dealt with the smallest pathogens, the prions and viroids .

He is the co-founder of several biotech companies , the most successful of which is the diagnostics company Qiagen , of which he was Chairman of the Supervisory Board until 2014. He also advises other biotechnological companies and gives lectures on this topic as well as on his actual research area in the field of molecular medicine.

Life

Riesner passed his Abitur in 1960 at the Burggymnasium in Essen . After studying physics and biophysics in Hanover, he did his doctorate in 1970 with Manfred Eigen at the Technical University of Braunschweig with a thesis on the physical chemistry of nucleic acids. From 1970 to 1973 he worked as an assistant at the Society for Biotechnological Research in Braunschweig and from 1974 to 1975 at the Institute for Clinical Biochemistry and Physiological Chemistry (Dept. G. Maass) of the Medical University of Hanover with the research focus on "Protein-nucleic acid, interaction, Structural changes of nucleic acid ”. In 1973 he worked as a postdoctoral fellow at Princeton University , USA at JR Fresco on electron microscopy of proteins. In 1975 he completed his habilitation with a thesis on "Biophysical Chemistry and Molecular Biology" at the Hannover Medical School.

From 1977 to 1980 he was professor for physical biochemistry at the Technical University of Darmstadt. He then worked until 2006 as professor and director of the Institute for Physical Biology at Heinrich Heine University in Düsseldorf . There he was also Dean and Vice Dean of the Faculty of Mathematics and Natural Sciences and Vice Rector for Research and Young Scientists. From his retirement in 2006 to the end of 2017 he was a member of the University Council of Heinrich Heine University.

Riesner also held visiting professorships at the Academia Sinica (Taiwan) and the University of California, San Francisco . He is also a member of the supervisory boards of AC Immune SA ( Lausanne ), evocatal GmbH ( Monheim am Rhein ), DIWA GmbH ( Düsseldorf ) and the DRK Blood Donation Service West gGmbH ( Hagen ).

Prices

Individual evidence

  1. Qiagen gets a new chief controller. In: rp-online.de. May 3, 2014, accessed February 18, 2018 .
  2. University Councilor Prof. em. Detlev Riesner receives the Order of Merit from the State of North Rhine-Westphalia. January 19, 2017, accessed February 18, 2018 .
  3. ^ Members of the University Council. uni-duesseldorf.de, accessed on February 18, 2018 .
  4. Ministerialblatt (MBl. NRW.) . Edition 2017 No. 4 from February 3, 2017, pages 59 to 70. Accessed February 5, 2017.
  5. ^ State Chancellery of the State of North Rhine-Westphalia: Awarded the State Order of Merit on January 18, 2017. Accessed on February 5, 2017.